Filing Details
- Accession Number:
- 0001140361-10-030899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-30 13:00:00
- Reporting Period:
- 2010-07-29
- Filing Date:
- 2010-07-30
- Accepted Time:
- 2010-07-30 17:25:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1000229 | Core Laboratories N V | CLB | Oil & Gas Field Services, Nec (1389) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1282547 | M David Demshur | 6316 Windfern Road Houston TX 77040 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2010-07-29 | 6,812 | $75.92 | 475,150 | No | 4 | S | Direct | |
Common Shares | Disposition | 2010-07-29 | 56,147 | $76.16 | 419,003 | No | 4 | S | Direct | |
Common Shares | Disposition | 2010-07-29 | 300 | $77.00 | 418,703 | No | 4 | S | Direct | |
Common Shares | Disposition | 2010-07-30 | 18,950 | $75.73 | 399,753 | No | 4 | S | Direct | |
Common Shares | Disposition | 2010-07-30 | 17,791 | $76.18 | 381,962 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 68,530 | Indirect | 401(k) Plan |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $75.00 to $75.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $76.00 to $76.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- On July 8, 2010, the common stock of Core Laboratories N.V. split 2-for-1 for shareholders of record as of June 30, 2010. All numbers and share prices in this Form 4 reflect this stock split.